4.7 Editorial Material

Bilirubin 2022: The Past, the Present and the Future

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

The Effects of Bilirubin and Lumirubin on the Differentiation of Human Pluripotent Cell-Derived Neural Stem Cells

Nikola Capkova et al.

Summary: The study compared the effects of bilirubin and its major photo-oxidation product on neural stem cells, showing that bilirubin exerted dose-dependent cytotoxicity while the photo-oxidation product had a substantial impact on cell morphology and protein redistribution.

ANTIOXIDANTS (2021)

Article Biochemistry & Molecular Biology

Long-Term Effects of Biliverdin Reductase a Deficiency in Ugt1-/- Mice: Impact on Redox Status and Metabolism

Giulia Bortolussi et al.

Summary: Inhibiting bilirubin production shows promise in preventing neurotoxicity in neonatal and adult settings. Deficiency of Bvra was found to prevent lethality and normalize bilirubin levels in adult mice, surpassing Ugt1(-/-) mice. Bvra(-/-)Ugt1(-/-) mice developed normally, with increased iron levels and reduced oxidative status in erythrocytes.

ANTIOXIDANTS (2021)

Review Biochemistry & Molecular Biology

Bilirubin as a Therapeutic Molecule: Challenges and Opportunities

Christopher A. Adin

Summary: Serum free bilirubin concentration has significant effects on morbidity and mortality in major health conditions such as cardiovascular disease, diabetes, and obesity/metabolic syndrome. Challenges in using bilirubin as a therapeutic agent in human patients include poor solubility, complex molecular structure, and concerns about animal-derived sources. However, advancements in drug delivery, biosynthetic strategies, and drug synthesis offer new possibilities for applying bilirubin as a pharmaceutical agent.

ANTIOXIDANTS (2021)

Article Biochemistry & Molecular Biology

Association of Serum Bilirubin and Functional Variants of Heme Oxygenase 1 and Bilirubin UDP-Glucuronosyl Transferase Genes in Czech Adult Patients with Non-Alcoholic Fatty Liver Disease

Jaromir Petrtyl et al.

Summary: The study revealed dysregulated bilirubin metabolism in NAFLD patients, likely due to increased oxidative stress, with no effect on NAFLD development from major functional variants in the HMOX1 or UGT1A1 gene promoters.

ANTIOXIDANTS (2021)

Article Biochemistry & Molecular Biology

Bilirubin Links HO-1 and UGT1A1*28 Gene Polymorphisms to Predict Cardiovascular Outcome in Patients Receiving Maintenance Hemodialysis

Yang Ho et al.

Summary: This study found that serum bilirubin levels and HO-1 and UGT1A1 gene polymorphisms were associated with cardiovascular disease among patients receiving chronic hemodialysis.

ANTIOXIDANTS (2021)

Article Biochemistry & Molecular Biology

Oxidative Stress and Related Biomarkers in Gilbert's Syndrome: A Secondary Analysis of Two Case-Control Studies

Karl-Heinz Wagner et al.

Summary: Subjects with Gilbert's syndrome show higher levels of antioxidant potential and protein oxidation products, as well as lower levels of apolipoprotein B, hs-C-reactive protein, interleukin 6, and interleukin 1 beta compared to healthy controls. Resting heart rate is also significantly lower in the GS group. Older subjects with GS demonstrate stronger protective effects.

ANTIOXIDANTS (2021)

Review Biochemistry & Molecular Biology

Serum Bilirubin Levels in Overweight and Obese Individuals: The Importance of Anti-Inflammatory and Antioxidant Responses

Lovro Ziberna et al.

Summary: This review paper discusses the relationship between obesity and bilirubin, highlighting that obese patients typically have lower serum bilirubin levels as bilirubin is a potent antioxidant molecule that helps alleviate inflammation. The study also proposes potential strategies to increase serum bilirubin levels in obese patients.

ANTIOXIDANTS (2021)